Wetcof Junior is a multi-component pediatric syrup formulated to provide symptomatic relief in respiratory conditions characterized by cough and mucus retention. Each 5 ml contains Ambroxol 15 mg, a mucolytic agent that facilitates the breakdown and clearance of viscous bronchial secretions, enhancing expectoration. Guaifenesin 50 mg acts as an expectorant, promoting the hydration and loosening of mucus in the airways, thereby aiding in productive cough. Menthol 2.5 mg provides a mild local anesthetic and cooling effect, which helps soothe irritated mucous membranes and reduce cough reflex sensitivity. Terbutaline 1.25 mg serves as a selective beta-2 adrenergic receptor agonist, inducing bronchodilation and improving airflow in obstructive airway conditions. Wetcof Junior is indicated for the management of acute and chronic bronchitis, bronchial asthma, and other respiratory disorders involving mucus hypersecretion and bronchospasm in children. It should be used under medical supervision, considering contraindications such as hypersensitivity to any component, cardiovascular disorders, and hyperthyroidism. Dosage should be adjusted according to age and clinical response. Adverse effects may include gastrointestinal discomfort, tremors, or allergic reactions. Wetcof Junior offers a comprehensive approach to pediatric respiratory care by combining mucolytic, expectorant, bronchodilator, and soothing agents in a single formulation.